Skip to Main Content
Back to News

Lobbying Update: $1,050,000 of ALIBABA GROUP HOLDING LIMITED lobbying was just disclosed

None

$1,050,000 of ALIBABA GROUP HOLDING LIMITED lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Small & medium sized enterprise export promotion Rights holder protection and anti-counterfeit initiatives Small & medium sized enterprise and agriculture export promotion; U.S. brand export promotion Foreign direct investment generally; issues related to proposed legislation barring state regulation of AI (budget reconciliation-H.R. 1, One Big Beautiful Bill Act, Sect. 43201(c)) Consumer product safety and e-commerce best practices Technology policy issues, no specific legislation Discussions regarding the Company's travel and tourism business E-commerce best practices regarding personal protection product safety Potential legislative and regulatory actions regarding access to U.S. capital markets Discussions on ongoing tariffs actions"

You can find more data on corporate lobbying on Quiver Quantitative.

BABA Congressional Stock Trading

Members of Congress have traded $BABA stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $BABA stock by members of Congress over the last 6 months:

  • REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $30,000 on 07/22, 06/09 and 1 sale worth up to $15,000 on 06/17.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

BABA Hedge Fund Activity

We have seen 547 institutional investors add shares of BABA stock to their portfolio, and 716 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BABA Analyst Ratings

Wall Street analysts have issued reports on $BABA in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Bernstein issued a "Outperform" rating on 10/10/2025
  • JP Morgan issued a "Overweight" rating on 10/01/2025
  • Jefferies issued a "Buy" rating on 09/29/2025
  • Baird issued a "Outperform" rating on 09/24/2025
  • B of A Securities issued a "Buy" rating on 09/24/2025
  • Susquehanna issued a "Positive" rating on 09/18/2025
  • Barclays issued a "Overweight" rating on 09/09/2025

To track analyst ratings and price targets for BABA, check out Quiver Quantitative's $BABA forecast page.

BABA Price Targets

Multiple analysts have issued price targets for $BABA recently. We have seen 12 analysts offer price targets for $BABA in the last 6 months, with a median target of $190.0.

Here are some recent targets:

  • Robin Zhu from Bernstein set a target price of $200.0 on 10/10/2025
  • Alex Yao from JP Morgan set a target price of $240.0 on 10/09/2025
  • Thomas Chong from Jefferies set a target price of $230.0 on 09/29/2025
  • Colin Sebastian from Baird set a target price of $174.0 on 09/24/2025
  • Joyce Ju from B of A Securities set a target price of $195.0 on 09/24/2025
  • Shyam Patil from Susquehanna set a target price of $190.0 on 09/18/2025
  • Jiong Shao from Barclays set a target price of $190.0 on 09/09/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles